ACI and Ethos Form New Clinical Trial Network

New opportunity for rapid approval of innovative therapies for the animal health market

WOBURN, Mass.--()--Animal Clinical Investigation (ACI) and Ethos Veterinary Health (Ethos) have formed a strategic alliance offering a new mechanism to deliver market approval of pharmaceuticals and therapeutics in Animal Health. This relationship offers a unique opportunity for collaboration with organizations in the pharmaceutical industry, diagnostic developers and medical device companies.

The two companies are establishing a multi-specialty clinical trial network comprised of a geographically diverse, nationwide collection of Ethos veterinary hospitals. They are selected based on their interest and experience in clinical research, and their depth and strength in the veterinary specialties of internal medicine, dermatology, oncology, emergency and critical care medicine, diagnostic imaging and surgery.

“This is an exciting partnership for Ethos,” said Ethos’ Chief Medical Officer Keith Richter, DVM, MSEL, DACVIM. “It will ensure that we are on the forefront of medical discoveries through the participation of our motivated doctors trained in the rigor of conducting clinical trials by ACI, a leading group in veterinary medicine that oversees trial delivery.”

ACI, focused on complex medical problems in animals and the design and execution of clinical trials, has been a leader in bringing clinical trials into the private practice setting. Adding the Ethos multi-specialty trial network to ACI’s previously assembled group expands its reach beyond oncology and dermatology.

Speaking on the new ACI-Ethos clinical trial network, ACI Chief Executive Officer Kristen Khanna, PhD, MBA, stated that, “We look forward to continuing to expand ACI’s role in clinical trial conduct in specialty medicine by joining with Ethos investigators and their staff. Ethos already practices medicine at the highest level – this opportunity allows Ethos and ACI to share our science-driven mindset with study sponsors and pet owners.”

The opportunity for rapid and successful approval of innovative therapies is a key benefit to study sponsors, based on the following:

  • Rapid accrual of data, resulting in faster studies, is enabled by the substantial caseload offered by the Ethos network and the optimized trial participation through ACI’s management
  • Highly motivated and experienced clinicians and medical monitoring ensure quality data
  • Ethos’ strategic focus on scientific innovation

Clinical studies in the areas of orthopedics, pain management, gastrointestinal disorders, immune mediated disease, oncology and the management of sepsis in dogs are currently being planned and will be among the first to be launched by the new ACI-Ethos multi-specialty network.

About Ethos Veterinary Health

Ethos is a veterinary health company with hospitals across the U.S. providing advanced medical care for pets. Our approach includes a focus on transformative science, continuous learning and growth for team members and collaboration. For more information visit ethosvet.com.

About Animal Clinical Investigation

ACI is a contract research organization bridging the veterinary community with the pharmaceutical and biotechnology industries to develop treatments for pets with cancer and other complex medical conditions. By working with pets with naturally occurring diseases, ACI also contributes to the growing body of research that can also inform human drug development. For more information visit animalci.com.

Contacts

GroundFloor Media
Nancy Shloss, 720-988-0402
nshloss@groundfloormedia.com

Release Summary

Animal Clinical Investigation and Ethos Veterinary Health have formed a strategic alliance offering a new mechanism to deliver market approval of pharmaceuticals and therapeutics in Animal Health.

Contacts

GroundFloor Media
Nancy Shloss, 720-988-0402
nshloss@groundfloormedia.com